Critical Care Nurse · 2003 · 30 citations · 40 references
MedicineNeurologyNeuroscienceNeurologic Critical CareNeurological Critical CareTrauma NeurosurgeryCerebral EdemaCerebral Perfusion MonitoringTraumatic Brain InjuryBrain Oxygenation MonitoringBrain Tissue Oxygen Pressure MonitoringBrain Trauma MonitoringCerebral Blood Flow AlterationsCerebral InjuryOxygen Delivery To BrainPrimary Brain InjuryTraumatic Brain Injury-induced Neuronal Death
This article provides an overview and historical perspective of the latest technology in brain tissue oxygen monitoring. Research findings on factors that affect the levels of brain tissue oxygen are presented, and the authors suggest interventions to maintain adequate brain oxygenation.Severe traumatic brain injury has challenged the medical community for decades. According to the Centers for Disease Control and Prevention,1 a traumatic brain injury is “an injury to the head that disrupts the normal function of the brain.” Almost 1.5 million cases of traumatic brain injury—some mild, some severe—are reported each year in the United States. Approximately 50000 of the persons who have a traumatic brain injury die, and 80000 leave the hospital with some disability. Currently, about 5.3 million persons in the United States live with a disability caused by a traumatic brain injury.1 The primary injury, which happens at the time of the event, causes the disruption of axons, cell bodies, and the integrity of the cell membrane, resulting in an accelerated disintegration of cell structure and function and, eventually, cell death.2 Secondary injury occurs in response to unchecked cerebral edema, ischemia, and the chemical changes associated with direct trauma to or systemic effects on the brain.Historically, the management of traumatic brain injury focused on the management of intracranial pressure (ICP) and cerebral perfusion pressure (CPP) via a variety of technologies. ICP monitoring has never been scrutinized in a prospective randomized study. However, most clinicians agree that monitoring provides information that can improve patients’ outcomes when targeted interventions are used to control ICP and CPP. This agreement was indicated by the acceptance of the Guidelines for the Management of Severe Brain Injury, published in 2000 by the Brain Trauma Foundation, and guideline-compliant care.3,4The concept of managing and treating only ICP in brain injury limits the ability to assess perhaps one of the most important parameters: oxygenation. The delivery and use of oxygen at the cellular level, in addition to control of the excitatory amino acids, can directly affect tissue survival. Technological advances in brain tissue oxygen monitoring provide information on the cellular dynamics of oxygenation and a better understanding of the impact of low oxygen states in the brain on patients’ outcome. This technology enables practitioners to assess levels of brain tissue oxygen associated with secondary injury and with treatment interventions.5 In this article, we provide an overview and historical perspective of the latest technology in brain tissue oxygen monitoring, present research findings on factors that affect the levels of brain tissue oxygen, and suggest interventions to maintain adequate brain oxygenation.The Monro-Kellie doctrine states that the cranium is a closed box with essentially noncompressible contents of approximately 80% brain tissue, 10% blood, and 10% cerebrospinal fluid. These percentages remain constant through intrinsic regulatory mechanisms, but an increase in any one or more of the contents requires compensation and a decrease in the others. Under normal circumstances, the brain compensates to some degree through autoregulation, shunting of cerebrospinal fluid, and compliance. Once these compensatory mechanisms are exhausted, increases in ICP occur. If the pressure increases markedly, the amount of blood flow to brain tissue is reduced, thus compromising cerebral tissue oxygenation. The causes of tissue hypoxia and ischemia may be related to intracranial events (eg, edema, structural damage, intracranial hypertension, seizures, vasospasm), systemic events (eg, hypoxemia, hypotension, hypo-capnia, anemia, hyperthermia), or a combination of the two.The brain depends on the constant uninterrupted delivery of oxygen and glucose to prevent secondary ischemic injury. Any decrease in perfusion in the brain causes additional secondary ischemia and injury and results in poor outcomes.6 Because failure to deliver oxygenated blood to injured brain tissue is thought to be detrimental, Meixensberger et al7 suggest that monitoring the partial pressure of brain tissue oxygen (Pbto2) may help prevent hypoxic events and improve patients’ outcomes. Studies in Europe indicated that measurement of ICP and CPP alone does not accurately reflect the tissue oxygenation in injured brain.8 The development of Pbto2 monitoring adds to the information needed to target therapy in patients as they respond to the changes in blood flow, decrease in energy production, alteration in cellular response, and potential ischemia.9Because the interest of many practitioners is the sufficient delivery and use of oxygen in brain tissues for necessary cellular function, brain tissue oxygen monitoring should enable clinicians to measure the difference between delivery and consumption of oxygen. Developing an accurate and reliable method for measuring brain tissue oxygenation has been the priority of researchers during the past 15 to 20 years.Tissue oxygenation is heterogeneous in animal and human models and has been well defined since the 1960s by using the Clark cell method of measurement.10 A Clark cell polaro-graphic probe is a semipermeable membrane covering 2 electrodes, 1 silver and 1 gold. In the presence of dissolved oxygen crossing the membrane, an electrical current is generated and is transferred to a monitor for interpretation. Early trials of tissue oxygen measurement were done in an animal model to ensure the usefulness and validity of the information derived from placement of the probe in both cerebrospinal fluid and tissue.11 In both animals and humans, accurate placement of the probe in the lateral ventricle is easily accomplished.12 Values obtained reflect the expected and appropriate changes during manipulation of the blood pressure and oxygenation and correlate with measurements taken in the deep white matter of the brain. A distinct drawback in measuring oxygen in the cerebrospinal fluid of the ventricles, however, is the condition of the ventricles in head injury. They are often slitlike because of secondary swelling, and monitoring in this circumstance does not provide an accurate measure of oxygenation in the tissue of the brain. Therefore, measuring the oxygen level in the tissue is obviously more useful. Further testing of probe placement revealed that measurements taken from the deep white matter of the brain are the most valuable and stable because oxygen consumption is most stable in that area.11 Placement of the probe in a bolt with a predetermined depth allows access to the white matter of the brain.Early evaluations of the measurement of oxygen in tissue included measurement of tissue temperature, because the temperature coefficient is needed to calculate the oxygen value. Several studies indicated that gradients exist between brain temperature and body temperature in the bladder, rectum, and jugular bulb. Although researchers have assumed that rectal temperature reflects brain temperature, Rumana et al13 found that brain temperature was consistently and significantly higher than the core body temperature after brain injury. Thirty patients were evaluated and monitored by using a LICOX oxygen/temperature probe placed in the parenchyma, a rectal temperature probe, and a jugular bulb catheter. In the initial 5 days after admission, mean brain temperature was 38.9°C (SD 1.0°C), and mean rectal temperature was 37.8°C (SD 0.4°C); both rectal and jugular venous oximetric (Sjvo2) temperatures were 1.1°C (SD 0.6°C) lower than mean brain temperature. The difference was more than 1°C in 18 patients and more than 2°C in 3; brain temperatures were lower than rectal temperatures in 2 patients. The temperature in the brain was also measured before and after the induction of barbiturate coma; values before and after induction did not differ significantly.In a small sample of 8 patients, Henker et al14 found that brain tissue temperature was underrepresented (ie, higher than bladder and rectal temperatures); mean brain temperature was 0.32°C to 1.9°C higher than bladder and rectal temperatures. In most patients, when the bladder and rectal temperatures were outside the normal range, the difference was even greater.Several studies indicated the importance of controlling fever in patients with severe head injury, and clinicians should be vigilant about the control of fever. Because temperatures are measured outside the cranium in most patients, the information may not necessarily be pertinent to the brain.15–17 At this time, we have not determined what temperature will have deleterious effects on patients, but we have observed a decrease in Pbto2 when patients become febrile.Although other monitoring systems are available for tissue oxygen monitoring, most studies have been done with the LICOX system (Integra NeuroSciences/GMS, Plainsboro NJ; Figure 1). This Pbto2 system was developed by Wolfgang Fleckenstein of Kiel, Germany, and has been used in tissue oxygen monitoring since the 1980s. The LICOX system includes a monitor with a screen for the display of oxygen and temperature values; cables that connect to the monitoring probes and to the bedside monitor: and a variety of probes for use in the brain, cardiac muscle, and peripheral muscles; under skin flaps; and during surgery. The ease of use and the pre-calibrated “smart” card that accompanies the probes make this single-step “system calibration” appealing to bedside nurses. The only additional time needed before monitoring is the tissue “settling” time after the microtrauma of insertion.18Values that indicate normal levels of tissue oxygen seem to vary between the available monitoring systems, possibly because the technology varies, causing some confusion among users. However, a consensus exists that low levels (<15 mm Hg) during the resuscitation phase of traumatic brain injury are predictive of poor outcomes. Initial (first 8–12 hours after injury) oxygen values were low in several studies.19–21 Data from at least one center indicated that early intervention and targeted protocol-driven management can positively affect the outcomes of patients with severe traumatic brain injury.22Debate over where to place the Pbto2 catheter is ongoing, with advantages and challenges in each application. Placement in the penumbra of an injury (Figure 2) is useful in assessing an increase in swelling and regional oxygenation. The challenge with this measurement is that the values reflect the local area and may not be indicative of the remainder of the uninjured brain. Placement in the so-called undamaged or normal tissue allows clinicians to use the values as a representation of somewhat normal global oxygen delivery (Figure 3) but may not reflect the subtleties of regional hypoxia.23–26With the development of the LICOX system, critical thresholds (ie, normal and abnormal levels of Pbto2) had to be determined. Additionally, information on the influence of various parameters on Pbto2, and the impact of oxygen monitoring on patients’ outcomes was needed.Numerous researchers in the 1990s sought to determine normal and abnormal levels of brain tissue oxygenation in both animal and human models. The researchers discovered that use of 2 different monitoring systems led to different normal and abnormal values.25,27–29 Our review of the literature on normal and abnormal Pbto2 here is confined to the LICOX monitoring system because the preponderance of research has been done with this system. It is also the system currently in use by clinicians at the bedside in the United States.Maas et al11 placed the oxygen sensor in the white matter of the frontal lobe and determined that baseline Pbto2 values were 25 to 30 mm Hg. Sarrafzadeh et al28 found that Pbto2 was between 20 and 35 mm Hg in uninjured brain tissue.Valadka et al25 studied 39 patients and found that extended periods with Pbto2 less than 15 mm Hg correlated with a greater chance of death. Any occurrence of a Pbto2 less than 6 mm Hg (no matter how long the time below this level) was associated with an increased risk of death. Therefore, Valadka et al considered a Pbto2 less than 15 mm Hg as a significant threshold. Bardt et al29 found that Pbto2 less than 10 mm Hg was associated with poor outcomes (ie, patients were severely disabled or died). Patients who experienced a Pbto2 of less than 10 mm Hg for longer than 30 minutes had the worst outcomes at discharge; 50% died and 50% were severely disabled. At 6-month follow-up, 22.2% of these patients had a favorable outcome, 22.2% were severely disabled, and 55.6% had died. In the group of patients who experienced a Pbto2 less than 10 mm Hg for less than 30 minutes, 80% were severely disabled or in a persistent vegetative state at discharge, yet their outcome at 6 months improved; 70% had a favorable outcome, 20% were severely disabled, and 10% had died.In a prospective randomized trial by van den Brink et al,30 101 comatose patients with head injury were evaluated after placement of the brain oxygen monitor. They were treated according to the European guidelines for the management of severe traumatic brain injury.31 Outcome at 6 months was determined by the score on the Glasgow Outcome Scale, which is used in early prediction of gross outcome after traumatic brain injury. Scores range from 1 to 5, with 1 indicating death and 5 indicating a good recovery.30 Despite aggressive management of ICP and CPP, numerous episodes of brain tissue hypoxia occurred. In the first 24 hours after injury, Pbto2 was lower than 15 mm Hg for longer than 30 minutes in 57 patients, lower than 10 mm Hg in 42, and lower than 5 mm Hg in 22. The severity and duration of tissue hypoxia were directly related to poor outcome and an increased risk of death and were an independent predictor of outcome.Practitioners must be cognizant of normal Pbto2 values and appreciate the effect that abnormally low values have on patients’ outcomes. With the LICOX monitoring system, the normal value is thought be 20 mm Hg or higher. Striving to maintain a Pbto2 of 20 mm Hg or higher is an acceptable starting point. Practitioners should be concerned and act quickly when the Pbto2 decreases to less than 15 mm Hg.30 In one study,25 4 of 5 patients with Pbto2 less than 5 mm Hg died.The risk of brain tissue oxygen monitoring has been detailed in a number of articles. In 9 studies,6,21,26,28,30,32–35 from 1996 through 2000, in which investigators examined safety parameters, infection, and/or hematoma in a total of 250 patients, only 2 adverse events occurred. No infections were reported, and the adverse events were related to small hematomas that occurred after catheter placement.26 Dings et al26 stated that because 3 probes were inserted through a bolt (ICP, temperature, and oxygen probes), determining which of the probes caused the bleeding was difficult. Because ICP monitoring was done in the reported cases26 through a bolt, the prevalence of hematoma (4.95%) was within the range associated with this type of ICP monitoring (ie, via a bolt).36Directly monitoring Pbto2 provides vital information on the effect of interventions in individual patients. During the past decade, brain tissue oxygen monitoring has been described by numerous authors,5,6,21,35 predominantly in Europe, where multimodality monitoring has been implemented in many intensive care units. Early monitoring of critical parameters in patients with traumatic brain injury can provide useful clinical information. Correlations of Pbto2 with parameters such as ICP, CPP, Sjvo2, and end-tidal carbon dioxide have been reported.5,21,37 Brain tissue oxygen monitoring can be used to provide information at the bedside about responses to clinical interventions and the success of the interventions.In the following sections, we address common interventions in the management of patients with traumatic brain injury. Measures are usually taken to ensure adequate perfusion, and the results are measured as the reduction in ICP and the increase in CPP. Strong evidence exists that hypotension and hypoxia should be avoided and CPP-guided therapy should be used in patients with severe brain injury.38,39 However, these measures are often unrelated to the delivery and utilization of oxygen in the brain.The administration of oxygen or titration of the fraction of inspired oxygen (Fio2) and its impact on Pbto2 has been investigated in several studies. In 22 patients with severe head injury, LICOX monitoring indicated that increasing the Fio2 led to an increase in Pbto2.33 Van den Brink et al35 examined the effects of preoxygenation before suctioning on Pbto2 in 82 patients with head injury. In 7 patients, a decrease in Pbto2 occurred during suctioning in 16 episodes when preoxygenation was omitted. In 142 episodes in which preoxygenation before suctioning was used, Pbto2 levels increased.35 In 9 patients with increasing the Fio2 to increased the low Pbto2 to et studied the effects of increasing to levels higher than the level necessary for during the early phase after severe brain injury in a randomized sample of 24 patients. In the patients in Fio2 was mean levels increased to (SD of the baseline in a and the levels of by This decrease in levels may indicate the of in the injured brain to levels of for the increase in Pbto2 associated with an increase in Fio2 is the of the dissolved oxygen in Although the dissolved oxygen in only to of the total oxygen to be the of oxygen from to clinicians have using oxygen therapy in patients with severe brain injury because of to associated with use of the but more aggressive management may have a place in the treatment of patients with severe brain to be a treatment for intracranial in some even has deleterious effects in patients with severe brain injury when used et found that ICP and increased CPP, brain tissue oxygenation decrease to as low as 10 mm Hg during Van den found that in of patients, Pbto2 during the first 24 hours after injury because of decreases in associated with It is well that in the first 24 hours after brain injury can hypoxia in the tissue at et al7 placed an oxygen probe in the during and observed patients who had secondary swelling and patients who had changes and had an increase in in brain tissue when they were oxygen. However, the group with swelling had between tissue and the group with changes In low tissue occurred in both after that some patients are at risk for hypoxia during this the of the cerebral blood thus blood flow and, oxygen CPP by ICP or increasing mean blood pressure can increase CPP can be by using or of cerebrospinal fluid, administration of and can decrease ICP, resulting in an increase in CPP. The impact of CPP therapy on Pbto2 has been investigated in several et discovered that when CPP was less than mm Pbto2 when CPP was greater than mm the effect on Pbto2 was et studied 7 patients with severe head injury and the between decreases in Pbto2 and CPP less than mm Hg. et the 2 that increasing CPP to more than mm Hg had effect on In their when CPP was increased from a mean of mm Hg (SD 9 mm Hg) to mm Hg (SD mm the Pbto2 increased from 24 mm Hg (SD mm Hg) to mm Hg (SD mm den found that the used to caused the CPP to with a resulting decrease in is common in the intensive care with an decrease in blood pressure and CPP. et reported that increasing CPP to normal levels and patients experienced hypoxic episodes during measurement of brain tissue oxygen. of the cerebral Dings et found a between CPP and Pbto2 changes in the 7 days after of a et also the of measurements of ICP, CPP, Sjvo2, and carbon dioxide with Pbto2 in 15 patients with traumatic brain injury. The of good was for Pbto2 with only for Sjvo2, the use of Pbto2 monitoring as an to ICP and CPP monitoring. and Pbto2 correlated with CPP during decreases in CPP, and the was when the CPP to a level less than a of mm They that tissue oxygen monitoring is and for a of 35 patients with severe head injury, Bardt et al29 found that during of ICP and decrease in CPP, the patients experienced cerebral hypoxia and that the degree and prevalence of these episodes the patients’ outcome. Pbto2 occurred in of the patients with an ICP of 20 mm Hg or et measured ICP and CPP during for and found that Pbto2 was when ICP was and that the effect was unrelated to CPP. They also found that Pbto2 was an of cerebral ischemia in these has been used to decrease ICP and improve CPP, but in a sample of patients with severe head injury, et found that ICP and CPP Pbto2 did The investigators that ICP was not a measure of ischemic have also been used to decrease et reported the impact of barbiturate therapy on Pbto2 in a of 10 patients with severe head injury. In 3 of the patients, was resulting in an increase in most patients with severe head injury, to increase CPP and decrease ICP improve The studies the for of care on each response to body temperature to less than that can decrease oxygen utilization in the In in a of the effects of in severe traumatic brain injury, outcome after 6 months did not differ significantly between patients who had and who did several reported between brain and body temperatures. many clinicians have found that increases in temperature are by a decrease in that CPP, level, ICP, and temperature and use of such as can affect oxygen delivery and/or consumption in brain The is a between of the parameters to ensure an adequate monitoring adds a to care of patients with severe traumatic brain injury. Research has a for interventions that can affect critical oxygen levels in the brain. understanding the causes of hypoxia and low oxygen states in the brain and interventions to oxygen the critical care can patients’ from injury.
40
Lack of Effect of Induction of Hypothermia after Acute Brain Injury
Guy L. Clifton, Emmy R. Miller, Sung C. Choi et al. · New England Journal of Medicine · 2001 · 1.4K citations · Full text
Intracranial pressure: to monitor or not to monitor?
Raj K. Narayan, P. R. S. Kishore, Donald P. Becker et al. · Journal of neurosurgery · 1982 · 591 citations
Medicine, Neurosurgery, Radiology +15
EBIC-Guidelines for management of severe head injury in adults
Andrew I.R. Maas, Mark Dearden, G. M. Teasdale et al. · Acta Neurochirurgica · 1997 · 581 citations · Full text